AMR Action Fund is a venture capital fund dedicated to developing new antibiotics and vital drugs to combat drug-resistant infections. It invests in companies at advanced growth stages, including BioVersys and Antabio, which focus on treating hard-to-treat infections. The fund also advocates for policy and market changes to ensure these essential drugs are developed and accessible.
